Followers | 283 |
Posts | 1162 |
Boards Moderated | 0 |
Alias Born | 10/04/2020 |
Thursday, December 09, 2021 10:01:31 AM
Well said on ALL points as always!
Look for my post between now and this weekend. I am presently in the process of emailing a comprehensive summary of RGBP to several Big Pharma CEOs that includes Eli Lilly, as to why they should consider Acquiring this Company.
I made a very strong case for that which includes the one you made here about the Human Patent for NF2R6 that was recently licensed to Oncology Pharma for 2 INDs for treating pancreatic & colon cancer byRNA Vaccine!
My summary is a concise read not only on the company's history with all its Disruptive Biotech Patents, but more so on what Dr. Koos has accomplished over the past 9 months with a link for all his SEC filings during this period.
If anything, it will no doubt DEFINITELY get their attention!!
In the line up of the CEOs I will be emailing is Gilead Sciences who acquired Kite Pharma in 2016 for $12 Billion that I believe was motivated in part due to Kite's mRNA Vaccine IND for treating various cancers!
Be well and prosperous...
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM